How many employees work at Diagnostica Stago?

About Diagnostica Stago

An In Vitro Diagnostic industry recognized worldwide in the exploration of Hemostasis and Thrombosis, the Stago group is expanding its scope to the field of delocalized biology by creating a subsidiary dedicated to this activity: Stago BioCare. Stago BioCare's mission is to provide clinical tools to guide the management of critical bleeding. This allows clinicians to choose the right treatment in the right time frame, significantly improving outcomes. This new subsidiary distributes in France and Belgium the Quantra system manufactured by HemoSonics (a Stago Group company based in the US. This system is intended to guide, at the patient's bedside, the transfusion strategy of healthcare professionals faced with emergency management. massive bleeding. The use of Quantra is part of a transfusion-saving approach with the main indications being cardiac, vascular/neurovascular, orthopedic surgery, liver transplantation as well as the management of multiple trauma patients and hemorrhage of delivery. Based on patented “SEER” ultrasound technology (Sonic Estimation of Elasticity via Resonance), the Quantra is fully automated and easily used by all healthcare professionals from a simple whole blood sample. The range of available tests make it possible to evaluate the patient's hemostatic profile via easily interpretable and reliable results in less than minutes.